Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Clinical trial NCT07475403 · RECRUITING
Trial details
- NCT number
- NCT07475403
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2028-04-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.